Amino Acids in Schizophrenia – Glycine, Serine and Arginine
- 28 March 2011
- book chapter
- Published by Springer Nature
- p. 253-262
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Testing the glutamate hypothesis of schizophreniaNature Neuroscience, 2010
- All Psychotic Roads Lead to Increased Dopamine D2High Receptors: A PerspectiveClinical Schizophrenia & Related Psychoses, 2008
- Psychosis pathways converge via D2High dopamine receptorsSynapse, 2006
- Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and AmphetamineArchives of General Psychiatry, 2005
- The GABA-glutamate connection in schizophrenia: which is the proximate cause?Biochemical Pharmacology, 2004
- Historical Development of the Dopamine Hypothesis of SchizophreniaJournal of the History of the Neurosciences, 2002
- The GABAergic system in schizophreniaInternational Journal of Neuropsychopharmacology, 2002
- The Emerging Role of Glutamate in the Pathophysiology and Treatment of SchizophreniaAmerican Journal of Psychiatry, 2001
- Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic caseseries outcome studyJournal of Psychopharmacology, 2001
- Dopamine in schizophrenia: a review and reconceptualizationAmerican Journal of Psychiatry, 1991